Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.
See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.
Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.
Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.
Explore essential insights on batch release processes to enhance compliance and quality. Dive into our article for practical guidance and best practices.
TITLE/ COMPANY | Issue Date | Status | Details |
---|---|---|---|
Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess. STAQ Pharma of Ohio, LLC |
16 May 2025 | Normal | Justification: Effective sample management is critical as proper sampling plans are essential to categorize and manage defect analysis. Excerpt: The acceptance sampling inspection governed by procedure SOP-0052 does not clearly define reinspection parameters. View Details |
The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed. Apothecary Pharma LLC |
15 May 2025 | Normal | Justification: Sample Management is affected due to improper vial handling, affecting the quality of inspections. Excerpt: Follow SOP2004 Visual Inspection by shaking and inverting the vials too forcibly. View Details |
Batch production and control records do not include in-process and laboratory control results for each batch of drug product produced. Apothecary Pharma LLC |
15 May 2025 | Normal | Justification: Sample Management is implicated due to the need for comprehensive documentation of inspection results for decision-making. Excerpt: You did not document complete results of 100% visual inspection... View Details |
In-process samples are not representative Aurolige Pharma LLC |
10 Apr 2025 | Normal | Justification: Sample Management is directly involved since it oversees the method and quality of in-process sample collection. Excerpt: There is no assurance that the sampling approach is a statistically representative of each product and each lot. View Details |
The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed. Wells Pharma of Houston LLC |
28 Mar 2025 | Normal | Justification: Sample Management is impacted by the failures in the visual inspection process, affecting defect detection. Excerpt: Your firm's visual inspection training program governed by SOP HOU-QA-006 is deficient. View Details |
View and learn more about FDA Inspections
with our comprehensive list of resources